Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 1/2 10Phase NA 9Phase 3 5Phase 1 4Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Breast Neoplasms 208Neoplasms 130Polycystic Ovary Syndrome 107Carcinoma, Hepatocellular 82Colorectal Neoplasms 77Prostatic Neoplasms 70Stomach Neoplasms 55Lung Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Carcinoma, Non-Small-Cell Lung 43Pain, Postoperative 42Pancreatic Neoplasms 41Head and Neck Neoplasms 38Pain 37Liver Neoplasms 36Leukemia, Myeloid, Acute 32Leiomyoma 32Keratosis, Actinic 31Colonic Neoplasms 31Recurrence 30Neoplasm Metastasis 29Multiple Myeloma 28Infertility 28Brain Neoplasms 28Uterine Cervical Neoplasms 26Urinary Bladder Neoplasms 24Ovarian Neoplasms 24Lymphoma 24Esophageal Neoplasms 23Obesity 22

Interventions

Tinzaparin 1Pharmacokinetics 1Enoxaparin 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Thrombocytopenia × Clear all
NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Ottawa Hospital Research Institute

Phase 4 Recruiting
50 enrolled
Classical hematology

Thrombocytopenia

NCT04861181 2025-05-22

NIRAPK

Hospices Civils de Lyon

Phase 4 Terminated
12 enrolled
Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡